Elan Corporation PLC
Treasury Building
Lower Grand Canal Street
Dublin
2
Tel: 353-1-709-4000
Fax: 353-1-709-4700
Website: http://www.elan.ie/
Email: epo@elancorp.com
437 articles about Elan Corporation PLC
-
Elan Corporation PLC Spends $380 Million to Repel Royalty Pharma Bid, Eyes More Deals With $1 Billion Warchest
5/20/2013
-
Elan Corporation PLC Announces Publication of Response Document
5/16/2013
-
Elan Corporation PLC Bets $1 Billion on Theravance, Inc. Drugs; Move to Spurn Its Hostile Suitor?
5/13/2013
-
Royalty Pharma Warns of Job Cuts if Elan Corporation PLC Bid Accepted
5/6/2013
-
Royalty Pharma Submits Formal Cash Offer for Elan Corporation PLC ("Elan")
5/2/2013
-
Elan Corporation PLC Reports First Quarter 2013 Financial Results
4/24/2013
-
Elan Corporation PLC Board Rejects Royalty Pharma Takeover Bid
4/22/2013
-
Johnson & Johnson Stake Sale Clouds Royalty Pharma Bid for Elan Corporation PLC
4/19/2013
-
Elan Corporation PLC Announces Final Results of Its Tender Offer
4/18/2013
-
Royalty Pharma Announces Firm Offer to Acquire Elan Corporation PLC
4/15/2013
-
Elan Corporation PLC Shareholders Approve Buyback as Royalty Pharma Fight Heats Up
4/12/2013
-
Elan Corporation PLC Announces Webcast of First Quarter 2013 Financial Results
4/11/2013
-
Elan Corporation PLC Announces Redemption of Its Senior Notes Due 2019
4/3/2013
-
Biogen Idec, Inc. (Massachusetts) Completes Purchase of Full Rights and Control of TYSABRI®
4/3/2013
-
Elan Corporation PLC Discloses Filing of Share Repurchase Tender Offer Documentation
3/13/2013
-
Elan Corporation PLC Provides Update on Tysabri Transaction and $1 Billion Share Repurchase
3/11/2013
-
Royalty Pharma Statement Regarding Elan Corporation PLC Proposal
3/6/2013
-
Elan Corporation PLC to Pay Shareholders Tysabri Dividends in Challenge to Bid
3/4/2013
-
Elan Corporation PLC Announces the Appointment of Mr. John Given as General Counsel
2/28/2013
-
Elan Corporation PLC Not Impressed With Royalty Pharma's $6.5 Billion Takeover Bid
2/27/2013